CWC
IART icon

Carolinas Wealth Consulting’s Integra LifeSciences IART Stock Holding History

Carolinas Wealth Consulting’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15
Closed -$861 – 1087
2023
Q1 		$861 Hold
15
– – ﹤0.01% 918
2022
Q4 		$841 Buy
+15
New +$763 ﹤0.01% 923

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carolinas Wealth Consulting's IART Position: Q2 2023 in Review

Carolinas Wealth Consulting sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 15 shares — an estimated $861 sold.

Carolinas Wealth Consulting first reported a position in IART in Q4 2022 and held it in 2 quarters. The position peaked at $861 in Q1 2023. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

  • Carolinas Wealth Consulting reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 15 Integra LifeSciences shares in Q2 2023, an estimated $861.
  • Carolinas Wealth Consulting first reported a position in Integra LifeSciences in Q4 2022 and held it in 2 quarters.
  • Carolinas Wealth Consulting's Integra LifeSciences position peaked at $861 in Q1 2023.
  • 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2023, filed 14 Aug 2023.